Analyse @AlbertBourla's tweets
I am incredibly excited to share that we are initiating the first Phase 3 study to evaluate the efficacy of our mRNA-based influenza vaccine candidate: on.pfizer.com/3LahWnT
Top Words | % |
---|---|
covid | 26.7% |
Top Applications | % |
---|---|
|
53.3% |
|
40.0% |
|
6.7% |
Top Content Types | % |
---|---|
URL | 26.7% |
Photo | 6.7% |
LOCATIONS
ANALYTICS